Major players in the coronavirus (COVID-19) current therapy market are Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Altimmune, Clover Biopharmaceuticals, Inovio Pharmaceuticals, Inc. , Biocryst Pharma, Gilead Sciences, and Regeneron Pharmaceuticals.

New York, Sept. 27, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Coronavirus (COVID-19) Current Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030” – https://www.reportlinker.com/p06151651/?utm_source=GNW

The global coronavirus (COVID-19) current therapy market is expected to grow from $14.63 billion in 2020 to $16.8 billion in 2021 at a compound annual growth rate (CAGR) of 14.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working,…

Read more…

Share.

Comments are closed.